R. Lafemina

发表

Inhibition of human immunodeficiency virus integrase by bis-catechols

D. Hazuda, E. Emini, R. Lafemina, 1995, Antimicrobial agents and chemotherapy.

trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus

G. Hayward, P. O’Hare, M. Pizzorno, 1988, Journal of virology.

A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background.

D. Hazuda, D. Graham, D. Olsen, 2006, Antiviral research.

Expression of the acidic nuclear immediate-early protein (IE1) of human cytomegalovirus in stable cell lines and its preferential association with metaphase chromosomes.

G. Hayward, J. Mosca, M. Pizzorno, 1989, Virology.

Differences in cell-type-specific blocks to immediate early gene expression and DNA replication of human, simian and murine cytomegalovirus.

G. Hayward, R. Lafemina, 1988, The Journal of general virology.

Viral long terminal repeat substrate binding characteristics of the human immunodeficiency virus type 1 integrase.

D. Hazuda, H. L. Robbins, E. Emini, 1994, The Journal of biological chemistry.

Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells

W. Schleif, H. L. Robbins, E. Roth, 1992, Journal of virology.

Structural implications of spectroscopic characterization of a putative zinc finger peptide from HIV-1 integrase.

H. L. Robbins, G. Sanyal, C. R. Middaugh, 1992, The Journal of biological chemistry.

Procede d'inhibition de la replication d'orthopoxvirus avec des composes de nucleoside

D. Olsen, R. Lafemina, Ann B. Eldrup, 2003 .

Peptide substrate cleavage specificity of the human cytomegalovirus protease.

E. Emini, R. Lafemina, K. LeGrow, 1994, The Journal of biological chemistry.

Substrate specificity of recombinant human immunodeficiency virus integrase protein

M. Cordingley, P. L. Callahan, R. Lafemina, 1991, Journal of virology.

Purification of active herpes simplex virus-1 protease expressed in Escherichia coli.

L. Kuo, P. Darke, E. Chen, 1994, The Journal of biological chemistry.

STRUCTURAL ORGANIZATION OF THE DNA MOLECULES FROM HUMAN CYTOMEGALOVIRUS

G. Hayward, R. Lafemina, 1980 .

Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum

R. Tewari, R. Lafemina, D. Sharma, 1977, Infection and immunity.

Structural organization of human herpesvirus DNA molecules.

G. Hayward, R. Ambinder, R. Lafemina, 1984, The Journal of investigative dermatology.

D,L-alpha-difluoromethylornithine inhibits human cytomegalovirus replication

R. V. van Breemen, W. Gibson, R. Lafemina, 1984, Journal of virology.

D , LOL-Difluoromethylornithine Inhibits Human Cytomegalovirus Replication

W. Gibson, R. Lafemina, A. Irmiere, 2022 .

Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication.

P. D. Cook, J. Tomassini, M. Maccoss, 2004, Journal of medicinal chemistry.

Antiviral research: strategies in antiviral drug discovery.

R. Lafemina, 2009 .

Morphological transformation by DNA fragments of human herpesviruses: evidence for two distinct transforming regions in herpes simplex virus types 1 and 2 and lack of correlation with biochemical transfer of the thymidine kinase gene.

G. Reyes, G. Hayward, R. Lafemina, 1980, Cold Spring Harbor symposia on quantitative biology.

Replicative forms of human cytomegalovirus DNA with joined termini are found in permissively infected human cells but not in non-permissive Balb/c-3T3 mouse cells.

G. Hayward, R. Lafemina, G. Hayward, 1983, The Journal of general virology.

A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties

Giovanni Migliaccio, D. Hazuda, J. Tomassini, 2004, Antimicrobial Agents and Chemotherapy.

Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro*

D. Hazuda, R. Cortese, J. Tomassini, 2003, Journal of Biological Chemistry.

Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs*

Lawrence C Kuo, Giovanni Migliaccio, L. Kuo, 2003, The Journal of Biological Chemistry.

Replication Fitness and NS5B Drug Sensitivity of Diverse Hepatitis C Virus Isolates Characterized by Using a Transient Replication Assay

D. Hazuda, D. Graham, D. Olsen, 2005, Antimicrobial Agents and Chemotherapy.

An in vitro Flaviviridae replicase system capable of authentic RNA replication.

J. Tomassini, L. Gan, R. Lafemina, 2003, Virology.

Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding site.

J. Condra, D. Graham, R. Lafemina, 1994, Biochemistry.

Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.

T. Nguyen, J. Condra, D. Graham, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Immunogenicity of Subcellular Fractions from Yeast Cells of Histoplasma capsulatum

R. Tewari, R. Lafemina, 1983 .

Constitutive and retinoic acid-inducible expression of cytomegalovirus immediate-early genes in human teratocarcinoma cells

G. Hayward, R. Lafemina, G S Hayward, 1986, Journal of virology.

Hepatitis C Virus Genetics and the Discovery of Mechanism-Based Inhibitors of the NS3/4A Protease and NS5B Polymerase

R. Lafemina, 2008 .

Characterization of a soluble stable human cytomegalovirus protease and inhibition by M-site peptide mimics

D. Hazuda, R. Lafemina, A. Marcy, 1996, Journal of virology.

Alternative Screening Approaches for Discovery of Middle East Respiratory Syndrome Coronavirus Inhibitors

R. Lafemina, 2014, Antimicrobial Agents and Chemotherapy.